ropofol (2,6-diisopropylphenol) is a short-acting intravenous anesthetic agent that has been widely used in pediatric anesthesia. However, several epidemiologic studies demonstrated that there was a link between an early anesthetic exposure and a potential risk for long-term learning and memory disabilities, 1, 2 raising serious concern about the safety of general anesthesia. Growing evidence in rodents and nonhuman primates also showed that prolonged exposure of developing animals to propofol potentiated γ-aminobutyric acid types A receptor activation 3, 4 and led to widespread neuronal cell death during the brain growth spurt through intrinsic or extrinsic pathways. [5] [6] [7] However, the detailed mechanisms that underlie the propofol-induced neurotoxic effects and the rational strategies for neuroprotection are lacking.
A recent study in fetal or neonatal nonhuman primates showed that propofol alone induced significant apoptosis of neurons and oligodendrocytes, but not astrocytes. 8 Astrocytes, the largest population of glial cells, play a pivotal role in early neurodevelopment in the central nervous BACKGROUND: Growing animal evidence demonstrates that prolonged exposure to propofol during brain development induces widespread neuronal cell death, but there is little information on the role of astrocytes. Astrocytes can release neurotrophic growth factors such as brainderived neurotrophic factor (BDNF), which can exert the protective effect on neurons in paracrine fashion. We hypothesize that during propofol anesthesia, BDNF released from developing astrocytes may not be sufficient to prevent propofol-induced neurotoxicity. METHODS: Hippocampal astrocytes and neurons isolated from neonatal Sprague Dawley rats were exposed to propofol at a clinically relevant dose of 30 μM or dimethyl sulfoxide as control for 6 hours. Propofol-induced cell death was determined by propidium iodide (PI) staining in astrocyte-alone cultures, neuron-alone cultures, or cocultures containing either low or high density of astrocytes (1:9 or 1:1 ratio of astrocytes to neurons ratio [ANR], respectively). The astrocyte-conditioned medium was collected 12 hours after propofol exposure and measured by protein array assay. BDNF concentration in astrocyte-conditioned medium was quantified using enzyme-linked immunosorbent assay. Neuron-alone cultures were treated with BDNF, tyrosine receptor kinase B inhibitor cyclotraxin-B, glycogen synthase kinase 3β (GSK3β) inhibitor CHIR99021, or mitochondrial fission inhibitor Mdivi-1 before propofol exposure. Western blot was performed for quantification of the level of protein kinase B and GSK3β. Mitochondrial shape was visualized through translocase of the outer membrane 20 staining. RESULTS: Propofol increased cell death in neurons by 1. Insufficient Astrocyte-Derived Brain-Derived Neurotrophic Factor Contributes to Propofol-Induced Neuron Death Through Akt/Glycogen Synthase Kinase 3β/Mitochondrial Fission Pathway system (CNS) partially through synthesizing and releasing growth factors. 9, 10 Brain-derived neurotrophic factor (BDNF) is a neurotrophin family of growth factor that can be largely secreted by astrocytes 11, 12 and critical for neurogenesis, learning, and memory. [13] [14] [15] Additionally, exposure of neonatal rat brains to propofol induced neurotrophin disturbance, such as downregulation of BDNF. 16 However, the cellular mechanisms linking BDNF to its potential signaling pathways in propofol-induced neurotoxic effects are largely unknown.
It has been shown that the postnatal ratio of neuronal and nonneuronal cells in rat CNS changes over time. 17 Under the physiological condition, the major type of cells in cortex and hippocampus are neurons (~90% neurons vs 10% nonneurons) at the first postnatal week. Then, neurons are gradually eliminated and replaced by nonneuronal cells. 17, 18 Compared with developing brains, the physiological ANR is higher (around 1:3 to 1:1) in adult animals. 19, 20 Thus, in this study, we isolated hippocampal astrocytes and neurons from neonatal rats. We used the low density (1:9) and high density (1:1) of astrocytes to neurons coculture models to mimic neonatal and adult rat brain physiological conditions in vitro, respectively. We hypothesized that insufficient levels of astrocyte-derived BDNF would contribute to propofol-induced neuron death through Akt/glycogen synthase kinase 3β (GSK3β)/mitochondrial fission pathway. An understanding of the underlying mechanisms may help to develop effective novel protective strategies for avoiding the anesthetic-induced neurotoxicity.
METHODS
The following is the outline of experimental design:
1. Analyzing the effect of propofol on the viability of cultured astrocytes and neurons isolated from neonatal rat hippocampus. Neurons or astrocytes alone were exposed to either propofol at clinically relevant concentrations (3, 10, or 30 μM) or dimethyl sulfoxide (DMSO) as a vehicle control. 2. Investigating the role of astrocytes in propofolinduced neuron death. Neurons were cocultured with low or high density of astrocytes (the ratios of astrocytes/neurons were 1:9 and 1:1, respectively) before treatment with propofol (30 μM). The neuron viability was then analyzed. 3. Examining whether astrocyte-secreted growth factors contribute to the protection against propofol-induced neuron death. Neurons were exposed to propofol in the presence or absence of astrocyte-conditioned medium collected from higher density of astrocytes. Meanwhile, BDNF was added to neurons-alone culture or cocultures containing low density of astrocytes before propofol exposure. The protective effect of increasing density of astrocytes or exogenous astrocyte-derived BDNF was determined by analysis of cell viability. 4. Analyzing the role of increased mitochondrial fission in propofol-induced neuron death. The mitochondrial morphology was assessed using translocase of the outer membrane 20 (TOM20; Santa Cruz, Dallas, TX) staining. Mitochondrial fission inhibitor Mdivi-1 was used to determine the functional role of mitochondrial fission in propofol-induced neuron death.
The detailed individual approach used in this study is described below.
Coculture of Hippocampal Neurons With Astrocytes
All rat experiments described were approved by the Institutional Animal Care and Use Committee at the Medical College of Wisconsin. Neurons were isolated for primary culture 21 with minor modifications. Briefly, hippocampi were isolated from 1-day-old Sprague Dawley rats in cold Hanks' balanced salt solution-4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer. The isolated hippocampi were then digested with 0.05% Trypsin-EDTA (wt/ vol; Invitrogen Corporations, Carlsbad, CA) for 15 minutes at 37°C with gentle shaking. The digestion was terminated by washing cells 3 times with neuron growth medium containing Neurobasal medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS; vol/vol; Invitrogen) and 0.5 mM glutamine (Invitrogen . After 2 hours of plating, the culture media were replaced with serum-free neuronal growth medium containing Neurobasal medium supplemented with 2% B27 (Invitrogen), 0.5 mM glutamine, penicillin (100 U/mL), and streptomycin (100 μg/mL; Invitrogen). Twenty-four hours later, C-Arabinoside (Sigma-Aldrich, St. Louis, MO) at a concentration of 5 μM was added to the medium for inhibition of cell proliferation. Half the media was changed every 2 days. It has been shown that hippocampal neurons are more sensitive to propofol on day 4 as compared to that on day 8 in vitro. 4 Thus, 4-day-old neurons (3 days after isolation) were used for both neuron and coculture experiments.
Astrocytes were isolated from 1-day-old Sprague Dawley rats following a previous protocol 22 with minor modifications. The hippocampi were incubated in digestion buffer containing DMEM (Invitrogen), 20 U/mL papain (Worthington Biochemical Corp, Freehold, NJ) and 1.5 × 10 −4 g/mL l-cystine (Sigma-Aldrich) for 45 minutes at 37°C with gentle shaking. Digestion was stopped by washing cells 3 times with astrocyte growth medium containing DMEM supplemented with 10% FBS (vol/vol). The cells were then plated on dishes precoated with 0.1% poly-l-lysine (wt/vol) solution (SigmaAldrich) at the density of 1 × 10 5 cells/cm 2 . After 24 hours, the medium was replaced with astrocyte growth media containing DMEM supplemented with 10% FBS and (penicillin [100 unit/mL] and streptomycin [100 μg/mL]). The media were changed every 2 days. Before propofol exposure, the astrocyte culture dishes were shaken for 4 hours at 300 rpm at 37°C to remove contaminated cells. Four-to 7-day-old astrocytes were used for the following neuron and coculture experiments.
For coculture experiments, 3 days after cell isolation, neurons plated onto the bottom of the culture plates were cocultured with astrocytes plated onto the Transwell inserts (Corning, Tewksbury, MA). The Transwell coculture system allows study of paracrine effects of one type of cells on another type of cells by physically separating 2 different types of cells. Astrocytes were cocultured with neurons at 2 different ratios (the astrocyte to neuron ratio was either 1:9 or 1:1) to mimic neonatal and adult rat brain physiological conditions in vitro, respectively. The cell viability of cocultured neurons was analyzed for 12 hours after 6 hours of propofol exposure.
Characterization of Astrocytes and Neurons by Immunofluorescence Staining and Confocal Microscopy
Neurons and astrocytes were seeded on Matrigel precoated glass cover slips at the density of 5 × 10 4 cells/cover slip. 23, 24 After 4 days in culture, the cover slips were fixed with 1% paraformaldehyde for 30 minutes at room temperature and treated with 0.5% Triton X-100 (Sigma-Aldrich) for 15 minutes, followed by incubation with 10% donkey serum for 20 minutes to block unspecific proteins. 
Propofol Exposure and Experimental Protocol
In children, plasma concentration of propofol to maintain and induce pediatric anesthesia is much lower (5.6-56 μM ~ 1-10 μg/mL). [25] [26] [27] Propofol is a highly lipophilic agent, and therefore, the concentration of propofol is relatively high (22-112 μM/4-20 μg/mL) in lipid-rich tissues such as the brain. [28] [29] [30] [31] [32] Different doses of propofol have been reported to induce neurotoxicity. For instance, Pearn et al 5 observed that 3 μM of propofol induced the significant increase in cleaved caspase-3 expression in neurons isolated from BALBc mice. Sall et al 33 showed that exposure of neonatal rat hippocampal neurons to as low as 5 μM of propofol resulted in increased neuron death. However, only a high dose of propofol (112 μM) could lead to cell death of 14-day rat cortical neurons. 34 The various doses of propofol that were able to induce neuron death in different studies may be due to the complexity factors among animal species, such as differences in ages, brain subregions, exposure duration, cell culture conditions, and end point measurements.
In our pilot studies, we tested the toxic effect of several doses of propofol (3-100 μM) on the cultured neonatal rat hippocampal neurons and astrocytes. The data showed that 6 hours of propofol exposure at the concentrations of 30 to 100 μM induced neuron death but did not influence astrocyte viability. Thus, 30 μM propofol (6 hours) was used in the mechanism study. Propofol (Sigma-Aldrich) was prepared as stock solutions at the concentrations of 3, 10, and 30 mM in DMSO (Sigma-Aldrich), which were then diluted to 1000 times in neuronal growth medium. An equal volume of DMSO was used as the vehicle control. After 6 hours of propofol exposure, the medium was washed and replaced with fresh neuronal growth medium in both DMSO-treated control and propofol-treated cultures. The cell death in neurons and astrocytes was assessed 12 hours after propofol exposure. LY290004 (10 μM, PI3K/ Akt inhibitor), cyclotraxin-B (25 μM, BDNF receptor TrkB inhibitor), CHIR 99021 (10 μM, GSK3β inhibitor), and BDNF (100 ng/mL) were administered in the presence of propofol. Mdivi-1 (25 μM, mitochondrial fission inhibitor) was given 30 minutes before propofol exposure. The concentrations of the inhibitors described above were determined based on others' reports 35, 36 and our pilot studies (data not shown).
Measurement of Cell Death by PI Staining
Cell death was determined by PI and Hoechst 33342 (SigmaAldrich) double staining. 4 PI is a DNA-specific red fluorescent dye that is only permeant to dead cells, while Hoechst 33342 is a blue fluorescent DNA-specific dye used for staining nuclei of both living and dead cells. Briefly, 12 hours after the propofol exposure, neurons and astrocytes were washed with phosphate-buffered saline, incubated with Hoechst 33342 (40 μM), and diluted in neuron basal medium for 15 minutes at 37°C. The medium was then replaced with PI (50 μM)-containing neuron basal medium at 37°C for 10 minutes. Fluorescent signals in the culture were imaged under the Inverted Fluorescence Microscope (Olympus, Japan) immediately after staining. Five samples and at least 20 images in each group were randomly chosen for assessment. The numbers of PI and Hoechst 33342 were counted using ImageJ software (National Institutes of Health, Bethesda, MD). Cell death was expressed as the percentage of PI-positive dead cells out of Hoechst 33342-positive total cells. In all experiments, cells were imaged and analyzed by an observer blinded to the experimental conditions.
Detection of Soluble Factors Released From Astrocytes Using Antibody Arrays
The astrocyte-derived soluble factors in the conditioned medium were assessed using L-Series Rat Antibody Array 90 (RayBiotech, Norcross, GA) following the manufacturer protocol. This array screens 90 paracrine proteins, including growth factors, cytokines, chemokines, angiogenic factors, and proteases soluble receptors released in astrocyte-conditioned medium. (The layout of different proteins in the membrane is available at the website: http://www. raybiotech.com/files/manual/Antibody-Array.)
Briefly, astrocytes (1 × 10 5 cells/cm 2 ) were exposed to 30 μM propofol or equal volume of DMSO for 6 hours, followed by 12-hour incubation in neuron basal medium. The medium was collected and concentrated 5 times and then loaded in the dialysis column. After the overnight dialysis, the protein concentration of dialyzed sample was determined using Bio-Rad Protein Assay Kit (Bio-Rad, Hercules, CA). The protein (5 mg/sample) was labeled with biotin for 30 minutes and went through the spin column for purification. The biotin-labeled samples were loaded on the array membrane, which was preprinted with capture antibodies, and incubated for 2 hours at room temperature. The membrane was then washed and incubated with horseradish peroxidaseconjugated streptavidin for 2 hours with gentle shaking. The intensity of dot immunoblot signals was detected using a chemiluminescence imaging system and quantified by www.anesthesia-analgesia.org
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Role of Astrocytes in Propofol-Induced Neuron Death densitometry using ImageJ software. The data were normalized by loading control (p-3b) and expressed as % control.
Enzyme-Linked Immunosorbent Assay Analysis of BDNF Concentration in Astrocyte-Conditioned Medium
The concentration of BDNF in astrocyte-conditioned medium was measured using rat BDNF sandwich enzymelinked immunosorbent assay Assay Kit (ChemiKine Millipore, Billerica, MA) following the manufacturer protocol. Briefly, 1 × 10 5 cells/cm 2 and 1.1 × 10 4 cells/cm 2 astrocytes were cultured in 30-mm dishes and considered as the high and low density of astrocytes, respectively. The medium was collected 12 hours after incubation with neuron basal medium and was subsequently concentrated 10 times. Fifty-microliter samples were assayed in the 96-well plates coated with mouse monoclonal antibody against BDNF. BDNF-specific biotin-conjugated second antibodies were added, followed by the streptavidin enzyme and substrate incubation. The absorbance of each sample was measured at 450 nm using Epoch spectrophotometer (BioTek, Winooski, VT). Protein concentrations in cell lysates were determined with Bio-Rad Protein Assay Kit. BDNF concentration in the astrocyte-conditioned medium was normalized by protein concentration and expressed as fold change (FC) of low-density astrocytes.
Measurement of Mitochondrial Fission by Confocal Microscopy
After 6 hours of propofol exposure, neurons on the cover slips from neuron-alone culture and 1:9 neuron-astrocyte coculture were washed with phosphate-buffered saline and fixed with 1% paraformaldehyde (wt/vol) for 30 minutes at room temperature. The shape of mitochondria was visualized by immunofluorescence staining (as described above), with the primary antibody against rabbit mitochondrial preprotein TOM20. The cover slips were then incubated with secondary antibodies Alexa Fluor 488 anti-rabbit immunoglobulin G (Invitrogen). The nuclei of neurons were labeled with Hoechst 33342 dye. The mitochondria were imaged using the laser-scanning confocal microscope (Nikon Eclipse TE 2000-U). Every single mitochondrial shape within neuronal processes (15 cells in each group) was evaluated by calculation of 2 factors: aspect ratio (AR) and form factor (FF), using ImageJ 1.41o software as described previously. 24, 37 Briefly, AR is a measure of the length of the mitochondria and is calculated as the ratio of the major to minor axes of the ellipse, while the FF is a measure of the degree of mitochondrial branching and is calculated using the equation: FF = perimeter2/4π × area. Both parameters have a minimal value of 1, representing a perfect circle. Healthy, elongated, and interconnected mitochondria have a high FF and AR, while fragmented, discontinuous mitochondria have low FF and AR values. In all experiments, neuronal cells were imaged and analyzed by an observer blinded to the experimental conditions.
Western Blot
After 6 hours of propofol exposure, neurons were collected and lysed in N-PER Neuronal Protein Extraction Reagent (Pierce; Thermo Scientific, Rockford, IL) containing protease inhibitor and phosphatase inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). Lysates were centrifuged at 10,000g for 15 minutes at 4°C. The supernatant was collected, and the concentration of each sample was determined using Bio-Rad Protein Assay Kit. The samples were denatured by boiling for 5 minutes at 97°C. A protein quantity of 15 μg/lane was loaded and separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The proteins in the gel were then transferred to polyvinylidene fluoride membrane. The membrane was preblocked with Starting Block Buffer (Thermo Fisher Scientific, Waltham, MA) and then incubated with primary antibodies against rabbit phosphorylated Akt (p-Akt; Ser473), rabbit anti-Akt, rabbit antiphosphorylated GSK3β (p-GSK3β; Ser9), rabbit anti-GSK3β (Cell Signaling, Danvers, MA), and β-actin (Abcam). After washing with Tris-buffered saline with Tween-20 (TBS-T), the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (Cell Signaling) for 1 hour at room temperature. The densities of immunoblots were quantified using ImageJ software, and the data were expressed as percentage of control.
Statistical Analysis
All data were expressed as individual values, mean values ± standard deviation, and 95% CI. Statistical analysis was performed using GraphPad Prism version 6.0 (GraphPad Software Inc, La Jolla, CA). The statistically significant differences of data between 2 groups were tested by Student t test. The 1-way analysis of variance and Tukey's post hoc test were used for testing multiple groups. A level of P < .05 was considered statistically significant. It has been reported that propofol at the concentrations ranging from 3 to 112 μM induced developmental neurotoxicity in animal cell model. 5, 33, 34 Thus, we first performed a pilot study and treated the cultured astrocytes or neurons with various concentrations of propofol in order to find the best representative concentration of propofol used for the neurons and astrocytes coculture studies. We found in our pilot study (n = 4/group) that the neuron death in control and protocol (30 μM) groups was 10.2 ± 1.31 and 18.6 ± 2.08, respectively. Accordingly, a study with a sample size of ≥4/group would be sufficient to detect the difference between the control and propofol groups at a significance level of .05, with a power of .8. In the current study, we selected the sample size of 5 to ensure the power of study.
RESULTS

Propofol Dose-Dependently Induced Cell Death in Neurons, But Not in Astrocytes
To determine whether propofol has a toxic effect on developing astrocytes and neurons, cell viability was measured using PI staining. Propofol exposure did not significantly alter the numbers of PI-positive dead astrocytes (PI% = 2.02, 95% CI, 1.75-2.3 in DMSO control; PI% = 1.93, 95% CI, 1.11-2.76 in 3 μM propofol; PI% = 1.92, 95% CI, 1.21-2.62 in 10 μM propofol; PI% = 2.06, 95% CI, 1.67-2.46 in 30 μM propofol; P < .05; Figure  1A ). In contrast, the numbers of PI-positive dead neurons were significantly increased by 1.5-and 1.8-fold after 10 and 30 μM propofol exposures compared with control (PI% = 15.5, 95% CI, 10.7-20.3 in 10 μM propofol; PI% = 18.6, 95% CI, 15.3-21.9 in 30 μM propofol; P < .05; Figure 1B) , respectively. In addition, we observed that the baseline dead astrocytes were lower than the dead neurons (2% in control astrocytes versus 10% in control neurons; Figure 1A 
Conditioned Medium From High Density of Astrocytes Attenuates Propofol-Induced Neuron Death
To determine the contribution of astrocytes to propofolinduced neurotoxicity, neurons were cocultured with 2 different densities of astrocytes (the ratios of astrocytes/ neurons were either 1:1 or 1:9) before 30 μM propofol exposure in Transwell coculture system. Astrocytes cocultured with a higher astrocyte to neuron ratio (1:1) significantly reduced the propofol-induced neuron death (FC = 1.17, 95% CI, 0.96-1.38; P < .05; Figure 2A ), while astrocytes cocultured with a lower astrocyte to neuron ratio (1:9) failed to protect the neurons against the propofol stress (FC = 1.87, 95% CI, 1.48-2.26; P > .05; Figure 2A ). To confirm whether the protective effect of astrocytes on neurons resulted from the secretion in the astrocyte-conditioned medium, neurons were exposed to 30 μM propofol in the presence or absence of astrocyte-conditioned medium collected from higher density of astrocytes. The conditioned medium from cultured astrocytes decreased propofolinduced neuron death by 38% (FC = 1.10, 95% CI, 0.77-1.43; P < .05; Figure 2B ).
Astrocyte-Secreted Soluble Factors Including BDNF in Conditioned Medium Are Downregulated by Propofol
To dissect the mechanisms of attenuation of propofol-mediated neuron death conferred by high-density Figure 3 , 90 protein expressions in the conditioned medium collected from DMSO-or propofol-treated astrocytes were analyzed using dot blot array. Among 90 proteins analyzed, 34 soluble proteins were detected in both DMSO-and propofol-treated astrocyte-conditioned medium ( Figure 3A [a] ). These 34 proteins include growth factors (vascular endothelial growth factor-C, platelet-derived growth factor-AA, and transforming growth factor β1), cytokines (interleukin [IL]-1β, IL-6, and IL-10), chemokines (macrophage inflammatory protein-1 α), neurotransmitters (Orexin A), transmembrane receptors (chemokine receptor type 4, nerve growth factor receptor, and toll-like receptor 4), matricellular proteins (matrix metalloproteinases-1), and so on ( Figure 3A [b] ). Of the 34 paracrine factors, propofol significantly reduced the level of 9 astrocyte-released growth factors and cytokines. Propofol decreased the release of growth factors BDNF, VEGF-C, PDGF-AA, and TGF-β1 by 47.4%, 40.9%, 76.6%, and 74.3%, respectively, compared with DMSO control. The secreted cytokines, such as IL-2, IL-3, IL-4, IL-5, and IL-6, were downregulated by propofol by 67.1%, 78.2%, 65.1%, 75.6%, and 71.9% (n = 4/group), respectively. These 9 downregulated paracrine factors have been shown to play important roles in neuron survival, learning, and memory. [38] [39] [40] [41] [42] [43] [44] Specifically, BDNF is directly involved in neuron survival. 44 
High Density of Astrocytes Attenuates PropofolInduced Cell Death Through BDNF/TrKB Signaling
To assess whether astrocyte-derived BDNF is cell density dependent, we compared the production of soluble BDNF in conditioned medium from the high density of astrocytes with that from the low density of astrocytes using enzymelinked immunosorbent assay. We found that first, BDNF secretion in the conditioned medium released from astrocytes at the higher density increased 2-fold compared with the lower density (FC = 1.97, 95% CI, 1.08-2.86 in high density; P < .05; Figure 4A ). Second, administration of recombinant BDNF attenuated propofol-induced cell death in both neurons alone and neurons cocultured with the low density of astrocytes (1:9 cocultures; FC = 0.8, 95% CI, 0.62-0.98 in neuron alone; FC = 0.85, 95% CI, 0.74-0.97 in 1:9 cocultured neurons; P < .05; Figure 4B ). Third, cyclotraxin-B, BDNF receptor TrkB inhibitor, increased neuron death in 1:1 cocultured neurons. However, blockade of TrkB receptor in 1:1 cocultured neurons did not completely abolish the highdensity astrocyte-induced reduction in neuron death (FC = 2.17, 95% CI, 1.74-2.6 in neurons; FC = 1.48, 95% CI, 1.30-1.67 in 1:1 cocultured neurons; P < .05; Figure 4C ).
High-Density Astrocyte-Induced Neuroprotection Against Propofol Is Partially Through AktMediated Glycogen Synthase Kinase 3β Signaling
To investigate whether high-density astrocyte-induced neuroprotection involves cell survival signaling, Akt inhibitor LY290004 was administered in 1:1 cocultured neurons in the presence of propofol. Western blot results showed that propofol significantly decreased the activation of Akt (p-Akt) in neurons, whereas the cocultured astrocytes attenuated the propofol-induced reduction in p-Akt (FC = 0.20, 95% CI, 0.07-0.33 in neurons; FC = 0.11, 95% CI, 0.007-0.22 in 1:1 cocultured neurons; P < .05; Figure 5A Astrocytes protect propofolinduced neuron death through conditioned medium. A, Astrocyte cell number dependently rescued the propofol-induced cell death in neurons when cocultured with neurons. Neurons were cocultured with 2 different densities of astrocytes (the ratios of astrocytes/neurons were either 1:1 or 1:9) in Transwell plates that physically separated astrocytes from neurons. The coculture was then exposed to 6 h of 30 μM propofol or DMSO as a control. Cell death was measured 12 h after propofol exposure and expressed as fold change of control. Cocultured astrocytes with the higher ratio against neuron cell counts (1:1), but not with the lower ratio (1:9), attenuated the propofol-induced neuron death (n = 5; *P < .05). B, Conditioned medium collected from the higher density of astrocytes attenuated the propofolinduced neuron death. Neurons were exposed to 6 h of 30 μM propofol in the presence or absence of astrocyteconditioned medium. Cell death was measured 12 h after propofol exposure and expressed as fold change of control (n = 4; *P < .05). DMSO indicates dimethyl sulfoxide. http://www.raybiotech. com/files/manual/AntibodyArray). B, Among 34 detected soluble factors, propofol downregulated the secretion of 9 key growth factors and cytokines that are important for neuron survival (eg, BDNF was indicated in the protein array maps) from astrocytes compared with DMSO control. Conditioned medium was collected 12 h after 6 h of 30 μM propofol exposure. The protein expression in conditioned medium was normalized as percentage of p-3b internal control using dot analysis (n = 4; *P < .05) versus relative control. BDNF indicates brain-derived neurotrophic factor; DMSO, dimethyl sulfoxide.
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Consequently, the astrocyte-induced reduction in cell death in 1:1 cocultured neurons was abolished by Akt inhibitor LY290004 (FC = 1.78, 95% CI, 1.50-2.05 in 1:1 cocultured neurons; P < .05; Figure 5C ). However, LY290004 alone did not cause the increase in neuron death (FC = 1.16, 95% CI, 0.63-1.69; P > .05; Figure 5D ).
To examine whether GSK3β is a downstream target of Akt signaling, the effect of LY290004 on GSK3β expression in the 1:1 cocultured neurons was analyzed using Western blot. Propofol decreased inactivation of GSK3β (p-GSK3β), while astrocytes attenuated propofol-induced decrease of p-GSK3β. This astrocyte-mediated and altered p-GSK3β was abolished by Akt inhibitor LY290004 (FC = 0.65, 95% CI, 0.44-0.85 in neurons; FC = 0.79, 95% CI, 0.61-0.97 in 1:1 cocultured neurons; P < .05; Figure 5B [a] and [b] ). Additionally, the propofol-induced increase in cell death in 1:9 cocultured neurons was rescued by GSK3β inhibitor CHIR99021 (FC = 1.08, 95% CI, 0.84-1.32; P < .05; Figure 5E ).
Insufficient BDNF Secretion Due to Low Density of Astrocytes Contributes to Propofol-Induced Mitochondrial Fission Through GSK3β-Mediated Signaling
To determine whether the increased mitochondrial fission contributes to the propofol-induced neuron death, mitochondrial morphology was assessed using TOM20 immunofluorescence staining. Mitochondrial fission inhibitor Mdivi-1 was used to block mitochondrial fission before propofol administration. After propofol exposure, shorter and fragmented mitochondria were prevalent in the neuron alone and 1:9 cocultured neurons compared to the interconnected and tubular mitochondria in control neurons. Mdivi-1 attenuated the propofol-induced mitochondrial fragmentation evidenced by the elongated mitochondria ( Figure 6A [a] ). Propofol significantly decreased the values of AR and FF of mitochondria in the neuron-alone culture and 1:9 neuronastrocyte coculture, indicating enhanced mitochondrial fission (AR = 2.76, 95% CI, 2.28-3.25 and FF = 2.33, 95% CI, 2.04-2.63 in neurons; AR = 2.76, 95% CI, 2.2-3.31 and FF = 2.33, 95% CI, 1.91-2.75 in 1:9 cocultured neurons; P < .05; Figure 6A To examine whether insufficient numbers of astrocytes and inadequate levels of BDNF contribute to propofolinduced mitochondrial fission, the high density of astrocytes and recombinant BDNF were added in the neuron-alone culture and 1:9 cocultures. Both exogenous BDNF administration and the high density of astrocytes attenuated the propofol-induced mitochondrial fission as evidenced by the increased AR and FF in neuron-alone culture and 1:9 neuron-astrocyte cocultures (AR = 4.58, 95% CI, 4.27-4.89 and FF = 3.11, 95% CI, 2.77-3.45 in neurons treated with BDNF; Figure 4 . High density of astrocytes compared with low density of astrocytes in the coculture attenuates propofol-induced neuron death through BDNF/TrkB pathway. A, Astrocyte cell density dependently released BDNF. BDNF secretion in conditioned medium released from high-density astrocytes was higher than that from low-density astrocytes. BDNF concentration was measured in astrocyte-conditioned medium by ELISA (n = 4; *P < .05) versus low-density astrocytes. B, Recombinant BDNF (100 ng/mL) rescued the propofol-induced neuron death both in neuron-alone culture and cocultured neurons with low density of astrocytes (ratio of astrocytes/neurons, 1:9). C, Inhibition of BDNF binding receptor TrkB activation in neurons cocultured with high density of astrocytes (ratio of astrocytes/neurons, 1:1) blocked the astrocyte-induced neuroprotection (n = 5; *P < .05). BDNF indicates brain-derived neurotrophic factor; ELISA, enzymelinked immunosorbent assay; TrkB, tyrosine receptor kinase B. Figure 5 . High density of astrocytes compared with low density of astrocytes in the coculture attenuates propofol-induced neuron death through Akt/GSK3β pathway. A, The effect of propofol, cocultured high density of astrocytes, and Akt inhibitor LY290004 on Akt expression in the neurons analyzed using Western blot. A (a), Representative Western blot bands of Akt, p-Akt, and β-actin. A (b), Astrocytes attenuated propofolinduced decrease of activation of Akt (p-Akt). This astrocyte-mediated effect was abolished by LY290004. P-Akt level was expressed as fold change of control without propofol treatment (n = 6; *P < 0.05 versus control; # P < 0.05 versus propofol). B, The effect of propofol, cocultured high density of astrocytes, and LY290004 on GSK3β expression in the neurons analyzed using Western blot. B (a), Representative Western blot bands of GSK3β, p-GSK3β, and β-actin. B (b), Astrocytes attenuated propofol-induced decrease of inactivation of GSK3β (p-GSK3β). This astrocyte-mediated effect was abolished by LY290004. The protein expression of p-GSK3β was expressed as fold change of control (n = 6; *P < .05 versus control; # P < .05 versus propofol). C, The astrocyte-induced reduction in neuron death in 1:1 astrocyte-neuron coculture was abolished by Akt inhibitor LY290004. D, LY290004 alone did not cause the increase in cell death in neurons (n = 4). E, The propofol-induced increase in neuron death in 1:9 astrocyte-neuron coculture was rescued by GSK3β inhibitor CHIR99021 (n = 5; *P < .05). Akt indicates protein kinase B; GSK3β, glycogen synthase kinase 3β; p-Akt, phosphorylated (ser 473) protein kinase B; p-GSK3β, phosphorylated GSK3β (ser 9). AR = 4.23, 95% CI, 3.36-5.10 and FF = 3.50, 95% CI, 2.74-4.25 in 1:9 cocultured neurons treated with BDNF; AR = 3.82, 95% CI, 3.44-4.20 and FF = 3.78, 95% CI, 3.43-4.13 in cocultures with high-density astrocytes; P < .05; Figure 6B [a] and [b] ).
To determine whether GSK3β plays a role in propofolinduced mitochondrial fission, CHIR99021 was used to inhibit propofol-induced increase of GSK3β activation. CHIR99021 attenuated the propofol-induced decrease of AR and FF in neuron-alone culture and 1:9 astrocyte-neuron cocultures, suggesting the decreased mitochondrial fission (AR = 4. 
DISCUSSION
In the current study, we examined the roles of astrocytes in propofol-induced cell death of the neurons isolated from neonatal rat hippocampus and the underlying mechanisms of BDNF, Akt, GSK3β, and mitochondrial fission using cultured neurons alone, astrocytes alone, and neurons cocultured with low and high density of astrocytes models. We demonstrated for the first time that: (1) propofol at clinically relevant concentrations dose-dependently induced neuron death but did not influence astrocyte viability; (2) cocultured astrocytes at the high density were able to rescue propofol-induced neuron death through astrocyte-secreted soluble factors, while astrocytes at the low density were unable to protect neurons Figure 6 . (Continued) Insufficient BDNF in the low density of astrocytes in the coculture contributes to propofol-induced neuron death through BDNF/ GSK3β/mitochondrial fission pathway. A, Propofol-induced increase of mitochondrial fission contributes to neuron death in both neuron-alone culture and astrocyte-neuron coculture with the low density of astrocytes (ratio of astrocytes/neurons, 1:9). A (a), The representative confocal fluorescence images of mitochondria in neuron-alone culture and 1:9 neuron-astrocyte coculture. After 6 h of 30 μM propofol exposure, mitochondria were labeled with the mitochondrial dye TOM20 (green) using immunofluorescence staining and imaged by confocal microscopy. The blue are cell nuclei stained with Hoechst 33342. In the control and Mdivi-1--treated neurons, the mitochondria were interconnected and tubular. After propofol exposure, much shorter and fragmented mitochondria exhibiting punctate signals were prevalent in the cells. A (b and c), Quantification of mitochondrial shape in the neurons by measuring both aspect ratio and form factor represent mitochondrial length and mitochondrial branching, respectively. Propofol significantly decreased the values of aspect ratio and form factor in neuronal processes of neuron-alone culture and 1:9 astrocyte-neuron coculture, indicating enhanced mitochondrial fission, while Mdivi-1 prevented propofol-induced mitochondrial fragmentation by increasing both aspect ratio and form factor. A (d), Inhibition of mitochondrial fission by Mdivi-1 rescued propofol-induced neuron death in neuron-alone culture and 1:9 astrocyte-neuron coculture. B, The effect of BDNF administration and cocultured high density of astrocytes on propofol-induced mitochondrial fission in neurons. B (a and b), BDNF administration attenuated the propofol-induced mitochondrial fission by increasing both aspect ratio and form factor in neuron-alone culture and 1:9 astrocyte-neuron coculture. The high density of astrocytes attenuated the propofol-induced mitochondrial fragmentation in neurons (ratio of astrocytes/neurons, 1:1). C, The effect of GSK3β inhibitor CHIR99021 on propofol-induced mitochondrial fission in neuron-alone culture and 1:9 astrocyte-neuron coculture. C (a and b), CHIR99021 attenuated the propofol-induced neuron mitochondrial fission by increasing both aspect ratio and form factor (n = 5; *P < .05).
ANESTHESIA & ANALGESIA
Role of Astrocytes in Propofol-Induced Neuron Death (specifically, astrocytes secreted BDNF in a cell number--dependent fashion and subsequently prevented propofolinduced neuron death); (3) propofol-induced neuron death occurs through Akt/GSK3β/mitochondrial pathway; and (4) insufficient BDNF secretion due to low density of astrocytes contributes to propofol-induced neuron death via Akt/ GSK3β/mitochondrial fission pathway.
Despite many findings in animal models that anesthetics induced neurotoxicity in the developing brain, 5, 8, 33, [45] [46] [47] there is little information regarding the role of astrocytes in the neurotoxicity. A recent finding demonstrated that glial cells from neonatal rat cortex cocultured with neurons prevented ketamine-induced neuron death, 48 indicating a protective role of supporting cells in ketamine-induced developmental neurotoxicity. The present study used dissociated hippocampal neurons and astrocytes in coculture system to address this current anesthetic issue. Our data showed that neurons cocultured with a low density of astrocytes (1:9 ratio cocultures) failed to reduce propofol-induced neuronal death. Conversely, high concentration of astrocytes (1:1 ratio cocultures) blunted the detrimental effect of propofol (Figure 2 ), suggesting that astrocytes exert neuroprotective effect, but the low ratio of astrocyte to neurons may be an important contributor to the increased vulnerability of the developing brain to anesthetics. As reported, the timing of great sensitivity of neurons to propofol is within 2 postnatal weeks in rodent brains. During this period of time, the structure of brain region and distribution of cell types differ greatly from those in adult brain. It has been reported that the glia to neuron ratio (GNR) varies widely across areas of the brain in developing rats. 17 In rat brain at postnatal day 7, GNR is 1:4.1 in cerebral cortex and 1:11.1 in hippocampus, while in adult rat brain (postnatal day 50), GNR increases to 1.35:1 in cerebral cortex and to 1.86 in hippocampus. Since GNR varies widely across areas of the brain in developing rat brains, future study will be focused to dissect the correlations between the vulnerability of different neonatal brain regions and subregions to propofol, and the GNR. It appears that the ratio of supporting cells to neurons is extremely crucial during the critical period of brain development.
The crosstalk between astrocytes and neurons in response to propofol is largely unknown. Astrocytes exert the capability to synthesize and release paracrine-soluble factors to surrounding neurons to promote neuron growth and survival. 49 This study is the first to report the protein profile of astrocyte-conditioned medium after propofol. Thirty-four cytokines and growth factors were identified out of 90 proteins; 9 neurotrophic factors secreted from astrocyte-conditioned medium that were downregulated after 6 hours of propofol exposure (Figure 3 ). Among 9 neurotrophic factors, BDNF, VEGF, PDGF, and TGF-β are a family of secreted proteins that participate in cell growth, survival, differentiation, and synaptic plasticity during brain development. [38] [39] [40] [41] [42] [43] [44] It has been shown that a single dose of propofol could change neurotrophin BDNF and NT-3 mRNA expression in mouse brain, 16 suggesting that the propofol-induced neurotoxic effect is largely caused by neurotrophic disturbance. For the first time, we reported that BDNF was secreted and released by astrocytes in a cell density--dependent manner. Given that the low density of astrocytes released the lower level of BDNF compared with the higher density may contribute to the sensitive vulnerability of neurons to propofol, and additional BDNF to neurons increase neuron survival ( Figure 4A and B) . BDNF is the most abundant neurotrophic growth factor expressed in hippocampus and is responsible for neurogenesis, learning, and memory; 11, 12, 35 we then focused on the BDNF role in propofol neurotoxicity in coculture study. Neurotrophin has 3 common Trk receptors: TrkA, TrkB, and/or TrkC. TrkA binds nerve growth factor at a high affinity. TrkB has specific binding affinity to BDNF, and TrkC binds closely to NT-3. The binding of neurotrophins to Trk receptors leads to the activation of signaling pathways. [50] [51] [52] We observed that conditioned medium-induced neuron survival was partially but not completely blocked by the selective TrkB inhibitor cyclotraxin ( Figure 4C ). It appears that BDNF may not be the sole player in neuroprotection. We cannot exclude the possibility that other neurotrophin factors such as VEGF-C, PDGF, and TGF-β may contribute to astrocyte-conditioned medium-induced neuron survival.
Next, we studied the mechanism by which astrocytederived BDNF increases cell survival of developing neurons. Understanding the mechanism underlying astrocyte-induced paracrine effect can help develop potential therapeutic strategies to avoid propofol-induced neurotoxicity. PI3K/Akt and GSK3β have been shown to be involved in various cell survival pathways, including developing human embryonic stem cellderived neurons. 23, 24, 53 Blockage of Akt, a negative regulator of GSK3β, or activation of GSK3β caused cells to undergo the apoptotic process. 54, 55 Furthermore, tyrosine phosphorylation of GSK3β led to GSK3β inactivation. Ketamine was reported to induce neuroapoptosis. This toxic effect was associated with the decrease in Akt and GSK3β phosphorylation (p-GSK3β), and coadministration of lithium with ketamine attenuated the neuronal death through deactivation of GSK3β. 53 Recently, evidence linking propofol-induced neurotoxicity and defective signal transducer and activator of transcription 3/sprouty homolog 2/Akt pathway was reported in human neurons. 23 Despite convincing evidence of involvement of Akt/GSK3β pathway in developing neuronal death, whether astrocytederived BDNF regulates this pathway to increase neuronal survival in propofol-injured neurons is unknown. In developing neurons, BDNF exerts its prosurvival effects commonly via 2 key signaling cascades. 56 In one pathway, BDNF activates Akt through its receptor TrkB-induced PI3K activity. In the second pathway, BDNF activates ribosomal S6 kinase 2 or mitogen-and stress-activated protein kinase 1 through TrkBinduced extracellular signal-regulated kinase 1/2 activation. In the present study, the data showed that BDNF increased cell survival through enhancing phosphorylation of Akt and its downstream p-GSK3β (Figures 5 and 6 ). Although Akt inhibitor LY290004 abolished astrocyte-mediated protection, LY290004 alone did not cause the increase in cell death in neurons ( Figure 5C and D) . This result suggests that decreased Akt activity may not be the only consequence of propofolinduced pleiotropic effects. Indeed, Straiko et al 57 reported that propofol at concentrations of 50 or 100 mg/kg suppressed the phosphorylation of extracellular signal-regulated kinase 1/2, another important survival kinase in mouse brain, implicating other molecular mechanisms in the dysregulation of intercellular organelles and intrinsic or extrinsic cell apoptosis process. These above findings provide new insights into the preventive strategies on the side effects of propofol in developing brain.
There are 2 limitations in the present study. One of the barriers lies in the relevance of the current in vitro coculture system to the in vivo animal model. In vitro cell culture approach can provide great benefits on: (1) investigating propofol toxicity under the controlled conditions and the potential mechanisms without interference of confounding physiology or pathology factors seen in the intact animal model; and (2) dissecting the contribution of individual types of neuronal cells from different brain regions to the anesthetic developing neurotoxicity. However, the in vitro system is always artificial. The real interaction among different cell types in intact animals may be missing in in vitro culture system. Under physiological condition, the interaction between neurons and astrocytes is more complex due to the participation of other types of glial cells such as oligodendrocytes. One recent study showed that propofol induced toxic effects in oligodendrocytes in nonhuman primate brains. 8 Thus, it is important to confirm our in vitro findings using intact animal model. As these experiments rely on an entirely artificial in vitro system, without additional experimentation in vivo, it is difficult to interpret the biological significance of the results presented in the current article. Another limitation underlies that in addition to Akt/GSK3β/mitochondrial fission pathway, additional signaling might also be involved as the mechanisms of propofol-induced neuron death. For example, micro ribonucleic acid-1 has been shown to negatively regulate BDNF secretion in CNS, 58 suggesting a potential role of micro ribonucleic acid-1 in the regulation of anesthetic-induced neurotoxicity. In addition, the current study only used apoptotic cell death as an end point. Propofol might exert other toxic effects, such as abnormalities in dendritic development, neuron stem cell proliferation, and synaptogenesis, which remain for future investigation.
In conclusion, we used neurons alone, astrocytes alone, and neurons cocultured with low and high ratio of astrocyte to neuron models to dissect the mechanisms involved in propofol-induced neuron death. We demonstrated for the first time that propofol-induced neuron death was partially through Akt/GSK3β/mitochondrial fission pathway. Similarly, the insufficient levels of BDNF due to the low ratio of astrocyte to neuron contributed to the neuron death via Akt/GSK3β/ mitochondrial fission pathway. The current study laid a foundation for the development of novel therapeutic strategies for ensuring the safety of pediatric anesthesia by interfering in the BDNF/Akt/GSK3β/mitochondrial fission pathways. E
